Boston Scientific Reports Results of Emblem S-ICD System in UNTOUCHED Study to Prevent Sudden Cardiac Death
Shots:
- The UNTOUCHED study involves assessing Emblem Subcutaneous Implantable Defibrillator (S-ICD) system in 1-116 patients with a left ventricular ejection fraction (LVEF) ≤35% + ischemic heart disease
- The UNTOUCHED study results: complication-free rate (95.8%) @30days post-procedure; induced ventricular fibrillation rates (99.2%); patients performed using a two-incision technique (69%); mean implant time (55.8 mins.)
- Emblem S-ICD system is an implantable cardioverter defibrillator- designed to treat & monitor heart rhythm problems and is implanted just under the skin with no wires touching the heart- eliminating the risk associated with electrical wires inside the heart or blood vessels
Ref: Boston Scientific | Image: Diagnostic and Interventional Cardiology
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com